Grifols(GIKLY) - 2021 Q2 - Quarterly Report

Investment - GIC, the sovereign wealth fund of Singapore, will invest approximately US$1 billion in Grifols' wholly-owned US subsidiary Biomat USA, Inc. in exchange for a minority stake[7] - Proceeds from GIC's investment will be used to repay debt[9] Operations - Biomat operates 296 plasma collection centers across the United States, maintaining control over day-to-day management by Grifols[8]